# Ceftaroline in the Treatment of Bone and Joint Infections

> **NCT02005068** · PHASE4 · WITHDRAWN · sponsor: **Orlando Health, Inc.**

## Conditions studied

- Osteomyelitis
- Joint Infections

## Interventions

- **DRUG:** Ceftaroline

## Key facts

- **NCT ID:** NCT02005068
- **Lead sponsor:** Orlando Health, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failed to enroll any patients despite study modifications
- **Last updated:** 2014-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005068, "Ceftaroline in the Treatment of Bone and Joint Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02005068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*